RecruitingNot ApplicableNCT06468618

Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients


Sponsor

Dana-Farber Cancer Institute

Enrollment

10 participants

Start Date

Aug 6, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Pediatric patients undergoing stem cell transplant (SCT) are hospitalized for extended periods and are at high risk for sleep disturbances. In order to begin to address the environmental issues that SCT recipients face during inpatient hospitalizations, investigators will conduct a single arm pilot study of a program entitled 'Developing Restful Environments and Management Strategies' (DREAMS). The program will provide children receiving SCT and families with information and a kit that includes tools which may support sleep and circadian health during an inpatient hospitalization.


Eligibility

Min Age: 9 YearsMax Age: 17 Years

Inclusion Criteria3

  • Patient aged 9-17 years.
  • Patient scheduled to receive a stem cell transplant at Boston Children's Hospital.
  • English speaking child and primary caregiver (parent/guardian).

Exclusion Criteria1

  • Primary team declines permission to approach.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALDREAMS Program Video and Care Kit

A pediatric, circadian health program comprised of an introductory video to sleep experiences for stem cell transplant recipients, strategies to improve sleep, and a Sleep and Circadian Care Kit which includes ear plugs, a white noise machine, an eye mask, a lightbox, and kit instructions. Actigraph, Fitbit, and tablet will be provided to participant and family.


Locations(2)

Boston Children's Hospital

Boston, Massachusetts, United States

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06468618


Related Trials